Crews respond to possible chemical contamination at hospital
Connecticut emergency officials are responding to a possible chemical contamination at a hospital where a patient had a plastic bag with the words "sodium cyanide" written on it.
Recalls this week: Light fixtures, smoke alarms
More than 4 million combination smoke alarm/carbon monoxide detectors are being recalled because they could fail to alert people to an incident.
White House to Make Obamacare Enrollment a Priority During Last Months
Getting more Americans to enroll for health insurance under President Barack Obama's healthcare law known as Obamacare is a top priority of his administration until President-elect Donald Trump takes office on Jan. 20, the White House said on Thursday.
Mitsubishi recalls 2 SUV models to fix windshield wipers
Mitsubishi is recalling two SUV models to fix problems that could cause the windshield wipers to malfunction.
Taxes? Trade? How Trump could affect key areas of economy
Donald Trump won the presidency by pledging to restore a vanished and golden economic era, when growth roared, factory jobs flourished and America sat unchallenged atop the global economy.
Volvo recalls 74,000 US vehicles to fix seat belt problem
Volvo is recalling about 74,000 cars and SUVs in the U.S. because the front passenger seat belt may not hold people in a crash.
Aetna CEO Expects Some ACA Benefits to Stay
Aetna Inc Chief Executive Officer Mark Bertolini said he expected some benefits of President Barack Obama's national healthcare reform law will stick under President-elect Donald Trump, like allowing young adults to stay on their family's health insurance.
Samsung's biotech unit debuts in Seoul. Here's what to know.
Samsung Biologics Co., the contract drug making unit of Samsung Group, made its market debut in Seoul on Thursday in South Korea's largest initial public offering in six years.
Drug firm AstraZeneca says 3Q earnings fall 12 percent.
Anglo-Swedish drugmaker AstraZeneca says third-quarter earnings fell 12 percent as its blockbuster cholesterol drug Crestor faced its first full quarter of competition in the United States from generic alternatives.
Mylan Working to Finalize EpiPen Settlement
Generic drugmaker Mylan NV said on Wednesday it was working to finalize a settlement with the U.S. government over Medicaid rebates for its EpiPen emergency allergy treatment, adding that money set aside for the settlement led to a third quarter loss.
Mylan sees 3Q loss due to settlement for EpiPen overcharges
Drugmaker Mylan Inc. swung to a third-quarter loss, mainly due to a big settlement for overcharging the federal government for its controversial EpiPen, the emergency allergy injector whose price Mylan has repeatedly jacked up.
Embattled Drugmaker Mylan's Earnings Disappoint
Generic drugmaker Mylan NV, which is under investigation and has faced harsh criticism over steep price increases for its EpiPen emergency allergy treatment, on Wednesday reported a third quarter loss due the cost of a proposed settlement with the U.S. department of Justice and other government agencies.
Small businesses can expect policy changes under Trump
The election of Donald Trump as the next U.S. president has small business advocates expecting policy changes on issues like health care and the environment.
New Outback model merges luxury, typical Subaru performance
Subaru makes an upscale turn in its versatile 2017 Outback SUV with a new Touring model that includes every feature as standard equipment and adds an expensive-looking interior, so much so that the leather seats with ivory-colored contrast stitching would look at home inside a pricey Range Rover SUV.
Obamacare Architect: Unclear to Me What Trump's Alternative is
Repealing Obamacare was a key focal point of President-elect Donald Trump’s campaign during the 2016 presidential race. Now that Trump has been elected, Obamacare Architect Dr. Ezekiel Emanuel weighs in on the uncertain future of the Affordable Care Act.
Marijuana Vote is Big Money This Election
California scores a win for pro-pot residents.
Walgreens Sues Theranos, Latest Hit for CEO Elizabeth Holmes
Walgreens Boots Alliance sued Theranos citing breach of contract, seeks millions...
CVS Cuts Profit Forecast, Shares Fall
Drugstore chain CVS Health cut its 2016 adjusted earnings forecast, citing slowing prescription growth and pharmacy network changes that will cause retail prescriptions to begin migrating out of its pharmacies this quarter.
Valeant's Revenue Falls, Cuts Forecast
Valeant Pharmaceuticals reported a smaller-than-expected quarterly adjusted profit and the company cut its full-year profit and revenue forecasts.














